Clinical trial
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by…
NCT00255684 · University of Rochester, Other · Terminated
Key facts
| NCT number | NCT00255684 |
|---|---|
| Title | Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer |
| Official title | Non-Myeloablative Conditioning and Unrelated Umbilical Cord Blood Transplantation for Children and Adults With Serious Oncohematologic Diseases |
| Lead sponsor | University of Rochester, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | graft-versus-tumor induction therapy, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, radiation therapy |
| Enrollment | 16 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2013 |
| Completion | Jun 1, 2016 |
| First posted | Nov 21, 2005 |
| Last update posted | Nov 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: